MedPath

南京泽恒医药技术开发有限公司

Ownership
-
Established
2009-10-15
Employees
-
Market Cap
-
Website
www.pharmtec.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Dopamine Hydrochloride Injection

Product Name
盐酸多巴胺注射液
Approval Number
国药准字H20254387
Approval Date
May 27, 2025
NMPA

Propranolol Hydrochloride Injection

Product Name
盐酸普萘洛尔注射液
Approval Number
国药准字H20254202
Approval Date
May 20, 2025
NMPA

Nimodipine Oral Solution

Product Name
尼莫地平口服溶液
Approval Number
国药准字H20253289
Approval Date
Jan 24, 2025
NMPA

Dobutamine Hydrochloride Injection

Product Name
盐酸多巴酚丁胺注射液
Approval Number
国药准字H20244807
Approval Date
Sep 3, 2024
NMPA

Pentoxifylline Injection

Product Name
己酮可可碱注射液
Approval Number
国药准字H20244248
Approval Date
Jun 28, 2024
NMPA

Chlorphenamine Maleate Injection

Product Name
马来酸氯苯那敏注射液
Approval Number
国药准字H20243659
Approval Date
May 8, 2024
NMPA

Macitentan Tablets

Product Name
马昔腾坦片
Approval Number
国药准字H20243313
Approval Date
Mar 5, 2024
NMPA

Salbutamol Sulfate Oral Solution

Product Name
硫酸沙丁胺醇口服溶液
Approval Number
国药准字H20234376
Approval Date
Oct 24, 2023
NMPA

Methotrexate Injection

Product Name
甲氨蝶呤注射液
Approval Number
国药准字H20234254
Approval Date
Sep 28, 2023
NMPA

Sugammadex Sodium Injection

Product Name
舒更葡糖钠注射液
Approval Number
国药准字H20233254
Approval Date
Mar 7, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.